Francesco Ricci

ScholarGPS® ID: 17215659623034

Affiliation

Institut Curie, France

Affiliation History

Field

Medicine

Discipline

Oncology

Top Specialties

Cancer | Breast Cancer | Neoplasm | Metastatic Breast Cancer | Radiation Therapy

Metrics Summary

Publication Count

Predicted Citations

1,150

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Dissociated Responses in Patients with Metastatic Solid Tumors Treated with Immunotherapy (journal article) Vaflard, Pauline \| Paoletti, Xavier \| Servois, Vincent \| Tresca, Patricia \| Pons-Tostivint, Elvire \| Sablin, Marie-Paule \| Ricci, Francesco \| Loirat, Delphine \| Hescot, Ségolène \| Torossian, Nouritza \| ... \| Le Tourneau, Christophe Drugs in R&D, volume 21, issue 4, pages 399-406 (2021). 10.1007/s40268-021-00362-3 Cited by (8) \| Cite \| Source
Circulating tumor DNA as a dynamic biomarker of response to palbociclib and fulvestrant in metastatic breast cancer patients (journal article) Darrigues, Lauren \| Pierga, Jean-Yves \| Bernard-Tessier, Alice \| Bièche, Ivan \| Silveira, Amanda Bartolini \| Michel, Marc \| Loirat, Delphine \| Cottu, Paul \| Cabel, Luc \| Dubot, Coraline \| ... \| Bidard, François-Clément Breast Cancer Research, volume 23, issue 1 (2021). 10.1186/s13058-021-01411-0 Cited by (38) \| Cite \| Source
HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast (journal article) Bièche, Ivan \| Coussy, Florence \| El-Botty, Rania \| Vacher, Sophie \| Château-Joubert, Sophie \| Dahmani, Ahmed \| Montaudon, Elodie \| Reyes, Cécile \| Gentien, David \| Reyal, Fabien \| ... \| Marangoni, Elisabetta Journal of Hematology & Oncology, volume 14, issue 1 (2021). 10.1186/s13045-021-01158-3 Cited by (8) \| Cite \| Source
Combination of Olaparib with radiotherapy for triple‐negative breast cancers: One‐year toxicity report of the RADIOPARP Phase I trial (journal article) Loap, Pierre \| Loirat, Delphine \| Berger, Frederique \| Cao, Kim \| Ricci, Francesco \| Jochem, Anne \| Raizonville, Laurence \| Mosseri, Veronique \| Fourquet, Alain \| Kirova, Youlia International Journal of Cancer, volume 149, issue 10, pages 1828-1832 (2021). 10.1002/ijc.33737 Cited by (21) \| Cite \| Source
One-Year Toxicity Report of the RADIOPARP Phase I Trial Evaluating Olaparib With Radiotherapy for Triple Negative Breast Cancer (journal article) Loap, P. \| Loirat, D. \| Berger, F. \| Rodrigues, M. \| Bazire, L. \| Pierga, J.Y. \| Ricci, F. \| Cao, K.I. \| Vincent-Salomon, A. \| Laki, F. \| ... \| Kirova, Y. International Journal of Radiation OncologyBiologyPhysics, volume 111, issue 3, pages S8- (2021). 10.1016/j.ijrobp.2021.07.052 Cite \| Source
Genomic Alterations in Head and Neck Squamous Cell Carcinoma: Level of Evidence According to ESMO Scale for Clinical Actionability of Molecular Targets (ESCAT) (journal article) Marret, Grégoire \| Bièche, Ivan \| Dupain, Célia \| Borcoman, Edith \| du Rusquec, Pauline \| Ricci, Francesco \| Hescot, Ségolène \| Sablin, Marie-Paule \| Tresca, Patricia \| Bello, Diana \| ... \| Kamal, Maud JCO Precision Oncology (2021). 10.1200/PO.20.00280 Cited by (26) \| Cite \| Source
OC-0630 Olaparib combined with radiotherapy for TNBC: 1-year toxicity report of the RADIOPARP phase 1 trial (journal article) Loap, P. \| Loirat, D. \| Berger, F. \| Rodrigues, M. \| Bazire, L. \| Pierga, J. \| Ricci, F. \| Cao, K. \| Vincent-Salomon, A. \| Laki, F. \| ... \| Kirova, Y. Radiotherapy and Oncology, volume 161 (2021). 10.1016/S0167-8140(21)06986-3 Cite \| Source
Inducible T-cell co-stimulatory (ICOS) receptor agonist, feladilimab (fela), alone and in combination (combo) with pembrolizumab (P): Results from INDUCE-1 urothelial carcinoma (UC) expansion cohorts (ECs). (journal article) Balar, Arjun Vasant \| Moreno, Victor \| Angevin, Eric \| Gan, Hui Kong \| Vieito, Maria \| Italiano, Antoine \| Danielli, Riccardo \| Massarelli, Erminia \| Opdam, Frans \| Chisamore, Michael Jon \| ... \| Ricci, Francesco Journal of Clinical Oncology, volume 39, issue 15_suppl, pages 4519-4519 (2021). 10.1200/JCO.2021.39.15_suppl.4519 Cited by (4) \| Cite \| Source
Implementing clinical practice guidelines for breast cancer management: searching for homogeneity in real-life heterogeneity (journal article) Ricci, Francesco Translational Breast Cancer Research, volume 2 (2021). 10.21037/tbcr-20-58 Cite \| Source
Combination of Olaparib and Radiation Therapy for Triple Negative Breast Cancer: Preliminary Results of the RADIOPARP Phase 1 Trial (journal article) Loap, Pierre \| Loirat, Delphine \| Berger, Frederique \| Ricci, Francesco \| Vincent-Salomon, Anne \| Ezzili, Cyrine \| Mosseri, Veronique \| Fourquet, Alain \| Ezzalfani, Monia \| Kirova, Youlia International Journal of Radiation OncologyBiologyPhysics, volume 109, issue 2, pages 436-440 (2021). 10.1016/j.ijrobp.2020.09.032 Cited by (32) \| Cite \| Source
RADIOPARP: A Phase I of Olaparib with Radiation Therapy (RT) in Patients with Inflammatory, Loco-regionally Advanced or Metastatic TNBC (Triple Negative Breast Cancer) or Patient with Operated TNBC with Residual Disease (journal article) Kirova, Y. \| Loirat, D. \| Berger, F. \| Ricci, F. \| Sablin, M.P. \| Vincent-Salomon, A. \| Laki, F. \| Mosseri, V. \| Ezzalfani, M. \| Fourquet, A. International Journal of Radiation OncologyBiologyPhysics, volume 108, issue 3, pages S26- (2020). 10.1016/j.ijrobp.2020.07.2117 Cite \| Source
Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer (journal article) Yu, Ke-Da \| Ye, Fu-Gui \| He, Min \| Fan, Lei \| Ma, Ding \| Mo, Miao \| Wu, Jiong \| Liu, Guang-Yu \| Di, Gen-Hong \| Zeng, Xiao-Hua \| ... \| Shao, Zhi-Ming JAMA Oncology, volume 6, issue 9, pages 1390- (2020). 10.1001/jamaoncol.2020.2965 Cited by (119) \| Cite \| Source
Efficacy and Safety of Trastuzumab Emtansine Plus Capecitabine vs Trastuzumab Emtansine Alone in Patients With Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer (journal article) Cortés, Javier \| Diéras, Véronique \| Lorenzen, Sylvie \| Montemurro, Filippo \| Riera-Knorrenschild, Jorge \| Thuss-Patience, Peter \| Allegrini, Giacomo \| De Laurentiis, Michelino \| Lohrisch, Caroline \| Oravcová, Eva \| ... \| Gelmon, Karen JAMA Oncology, volume 6, issue 8, pages 1203- (2020). 10.1001/jamaoncol.2020.1796 Cited by (22) \| Cite \| Source
Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study (journal article) Abida, Wassim \| Campbell, David \| Patnaik, Akash \| Shapiro, Jeremy D. \| Sautois, Brieuc \| Vogelzang, Nicholas J. \| Voog, Eric G. \| Bryce, Alan H. \| McDermott, Ray \| Ricci, Francesco \| ... \| Chowdhury, Simon Clinical Cancer Research, volume 26, issue 11, pages 2487-2496 (2020). 10.1158/1078-0432.CCR-20-0394 Cited by (271) \| Cite \| Source
Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trial (journal article) Tolaney, Sara M \| Wardley, Andrew M \| Zambelli, Stefania \| Hilton, John F \| Troso-Sandoval, Tiffany A \| Ricci, Francesco \| Im, Seock-Ah \| Kim, Sung-Bae \| Johnston, Stephen RD \| Chan, Arlene \| ... \| André, Fabrice The Lancet Oncology, volume 21, issue 6, pages 763-775 (2020). 10.1016/S1470-2045(20)30112-1 Cited by (144) \| Cite \| Source
Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma (journal article) Even, C. \| Lassen, U. \| Merchan, J. \| Le Tourneau, C. \| Soria, J-C \| Ferte, C. \| Ricci, F. \| Diener, J. T. \| Yuen, E. \| Smith, C. \| ... \| Massard, Christophe Investigational New Drugs, volume 38, issue 2, pages 402-409 (2020). 10.1007/s10637-019-00739-x Cited by (45) \| Cite \| Source
Genomic characteristics associated with clinical activity of rucaparib in patients (pts) with BRCA1 or BRCA2 ( BRCA ) - mutated metastatic castration-resistant prostate cancer (mCRPC). (journal article) Abida, Wassim \| Campbell, David \| Patnaik, Akash \| Sautois, Brieuc \| Shapiro, Jeremy David \| Vogelzang, Nicholas J. \| Bryce, Alan Haruo \| McDermott, Raymond S. \| Ricci, Francesco \| Rowe, Julie Haewon \| ... \| Chowdhury, Simon Journal of Clinical Oncology, volume 38, issue 6_suppl, pages 178-178 (2020). 10.1200/JCO.2020.38.6_suppl.178 Cited by (5) \| Cite \| Source
Comparative Analysis of Durable Responses on Immune Checkpoint Inhibitors Versus Other Systemic Therapies: A Pooled Analysis of Phase III Trials (journal article) Pons-Tostivint, Elvire \| Latouche, Aurélien \| Vaflard, Pauline \| Ricci, Francesco \| Loirat, Delphine \| Hescot, Ségolène \| Sablin, Marie-Paule \| Rouzier, Roman \| Kamal, Maud \| Morel, Claire \| ... \| Le Tourneau, Christophe JCO Precision Oncology (2019). 10.1200/PO.18.00114 Cited by (47) \| Cite \| Source
Reanalysis of the efficacy of molecular targeted agents (MTAs) given in the randomized trial SHIVA01 according to the ESMO ESCAT scale of actionability (journal article) Moreira, A. \| Vacher, S. \| Lecerf, C. \| Frelaut, M. \| Sablin, M.P. \| Loirat, D. \| Ricci, F. \| Hescot, S. \| Borcoman, E. \| Torossian, N. \| ... \| Kamal, M. Annals of Oncology, volume 30 (2019). 10.1093/annonc/mdz239.008 Cite \| Source
MonarcHER: A randomized phase II study of abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with HR+, HER2+ advanced breast cancer (ABC) (journal article) Tolaney, S.M. \| Wardley, A.M. \| Zambelli, S. \| Hilton, J. \| Troso-Sandoval, T. \| Ricci, F. \| Im, S.-A. \| Kim, S.-B. \| Johnston, S.R.D. \| Chan, A. \| ... \| André, F. Annals of Oncology, volume 30 (2019). 10.1093/annonc/mdz394.012 Cited by (24) \| Cite \| Source